Role of SREBP1 in atorvastatin-induced reduction of NLRP1 inflammasome ex-pression
10.3969/j.issn.1000-484X.2016.12.018
- VernacularTitle:SREBP1在阿托伐他汀抑制NLRP1炎性体表达中的作用
- Author:
Bo WANG
;
Siyang YU
;
Yang LIU
;
Yan WANG
;
Jianqiang XU
;
Gaofeng ZENG
;
Guojun ZHAO
- Keywords:
Atorvastatin;
Anti-inflammatory effect;
SREBP1;
NLRP1 inflammasome;
Atherosclerosis
- From:
Chinese Journal of Immunology
2016;32(12):1805-1808,1814
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To investigate the role of sterol regulatory element binding protein-1 (SREBP1) in atorvastatin-induced reduction of nucleotide-binding oligomerization domain-like receptor protein 1 ( NLRP1 ) inflammasome expression. Methods:THP-1 cells were treated with phorbol 12-myristate 13-acetate (160 nmol/L) for 12 h to be differentiated into macrophages. The medium was then replaced with serum-free medium containing lipopolysaccharide and ( or ) atorvastatin. The mRNA expression of NLRP1 and SREBP1 were detected by Real-time PCR. The protein expression of NLRP1 and SREBP1 were determined by Western blot. Furthermore, we observed the effect of SREBP1 siRNA on atorvastatin-induced reduction of NLRP1 expression. Results:Atorvastatin inhibited the mRNA and protein expression of NLRP1 and SREBP1 in the THP-1 macrophages. SREBP1 siRNA showed no significant difference on lowering NLRP1 expression when compared with atorvastatin. Treating cells with SREBP1 siRNA and atorvastatin at the same time resulted in more obvious reduction of NLRP1 expression than single use of SREBP1 siRNA or atorvastatin. Conclusion:Atorvastatin might exert anti-inflammatory effect by repressing NLRP1 expression through the SREBP1 path-way.
